The aim of this register is to determine the Accolade/Accolade II stem and Trident/Tritanium cup survivorship over years.
This is a prospective international multicentre surveillance register. The aim of this register is to determine the Accolade/Accolade II stem and Trident/Tritanium cup survivorship over years. All institutions willing to participate to the register, able to recruit at least 20 patients (up to 100 patients)
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
472
Total hip replacement
Total hip replacement
Total hip replacement
Ziekenhuis Netwerk Antwerpen
Antwerp, Belgium
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, Netherlands
Amphia Ziekenhuis
Breda, Netherlands
Maatschap Orthopaedie Ikazia
Rotterdam, Netherlands
Survivorship of the Device
Survivorship shown in Kaplan Meier survival curves (statistic used to estimate the survival function from lifetime data).
Time frame: 10 years Follow-up
Investigation of Clinical Performance and Patient Outcome With Modified Harris Hip Score (HHS) Patient Questionnaire
Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor
Time frame: pre-operative, 1, 3, 5, 7 and 10 years follow-up
Investigation of Clinical Performance and Patient Outcome With Oxford Hip Score Patient Questionnaire
Outcome instrument which contains 12 questions on activities of daily living that assess function and residual pain in patients undergoing total hip replacement (THR) surgery, each scored from 0-4 (worst to best), giving a final score with a total range of 0-48. A final score of 0 to 19 indicates severe hip arthritis, 20-29 indicates moderate to severe symptoms, 30-39 indicates mild to moderate symptoms, and 40 to 48 indicates satisfactory joint function.
Time frame: pre-operative, 1, 3, 5, 7 and 10 years follow-up
Investigation of Clinical Performance and Patient Outcome With EuroQuol-5 Dimension (EQ-5D) Patient Questionnaire
The EQ-5D is a subject-completed questionnaire designed to assess subject health state values. The EQ-5D consists of 2 areas: the EQ visual analogue scale (EQ VAS) and the EQ-5D descriptive system, time trade-off (TTO). The EQ VAS collects health state values using a 20 cm visual analogue scale with the endpoints labeled best imaginable health state at the top and worst imaginable health state at the bottom, having numeric values of 100 to 0 respectively. The EQ-5D Time Trade-off (TTO) descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/comfort and anxiety/depression. Each dimension has three levels: no problems, some problems and extreme problems. The TTO index values on a scale between -1(low) and 1(high) show the average health status according to the 5 dimensions. A low score shows worse health, and a high score shows better health.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Orbis Medisch Concern
Sittard, Netherlands
Rijnstate Arnhem
Zevenaar, Netherlands
Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm
Hässleholm, Sweden
Harrogate and District NHS Foundation Trust
Harrogate, United Kingdom
Time frame: pre-operative, 1, 3, 5, 7 and 10 years follow-up